Cellectis SA (NAS:CLLS)
$ 1.56 0 (0%) Market Cap: 154.13 Mil Enterprise Value: -15.24 Mil PE Ratio: 0 PB Ratio: 1.27 GF Score: 70/100

Q4 2019 Cellectis SA Earnings Call Transcript

Mar 05, 2020 / 12:30PM GMT
Release Date Price: $15.74 (-1.69%)
Operator

Good morning, everyone, and welcome to the Cellectis' Fourth Quarter and Full Year 2019 Results Conference Call. (Operator Instructions) Please be aware that today's conference call is being recorded.

I'd now like to introduce the first speaker, Simon Harnest, Cellectis' Vice President of Corporate Strategy and Finance. You may begin, sir.

Simon Harnest
Cellectis S.A. - VP of Corporate Strategy & Finance

Thank you, and welcome everyone to Cellectis' Fiscal Year and Fourth Quarter 2019 Corporate Update and Financial Results Conference Call. Joining me on the call today with prepared remarks are Dr. André Choulika, our Chairman and Chief Executive Officer; Eric Dutang, our Chief Financial Officer; and Dr. Francisco Esteva, Vice President, Clinical Development.

Yesterday evening, Cellectis filed its annual report and issued a press release reporting our financial results for the fourth quarter and year ended December 31, 2019. The reports and press release are available on our website at cellectis.com.

As a reminder, we will make

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot